Bank of America’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$396M Sell
10,769,699
-1,098,430
-9% -$52M 0.03% 469
2025
Q4
$604M Sell
11,868,129
-1,535,249
-11% -$78.5M 0.04% 355
2025
Q3
$744M Sell
13,403,378
-1,318,100
-9% -$77.2M 0.05% 333
2025
Q2
$1.02B Sell
14,721,478
-71,146
-0.5% -$4.84M 0.07% 255
2025
Q1
$1.03B Sell
14,792,624
-699,760
-5% -$57.8M 0.08% 230
2024
Q4
$1.33B Buy
15,492,384
+1,165,955
+8% +$126M 0.11% 177
2024
Q3
$1.71B Buy
14,326,429
+137,066
+1% +$18.3M 0.14% 152
2024
Q2
$2.03B Buy
14,189,363
+1,135,632
+9% +$150M 0.18% 122
2024
Q1
$1.68B Buy
13,053,731
+78,322
+0.6% +$9.32M 0.15% 136
2023
Q4
$1.34B Buy
12,975,409
+194,104
+2% +$19.2M 0.14% 160
2023
Q3
$1.16B Buy
12,781,305
+323,241
+3% +$28.5M 0.13% 170
2023
Q2
$1.01B Sell
12,458,064
-187,126
-1% -$15.3M 0.11% 198
2023
Q1
$1.01B Sell
12,645,190
-881,322
-7% -$62.5M 0.1% 201
2022
Q4
$915M Sell
13,526,512
-1,116,760
-8% -$65.5M 0.1% 204
2022
Q3
$729M Sell
14,643,272
-290,272
-2% -$15.5M 0.09% 231
2022
Q2
$832M Buy
14,933,544
+52,326
+0.4% +$2.9M 0.09% 212
2022
Q1
$826M Buy
14,881,218
+252,876
+2% +$13M 0.08% 232
2021
Q4
$819M Sell
14,628,342
-294,470
-2% -$16M 0.08% 236
2021
Q3
$716M Buy
14,922,812
+313,912
+2% +$15.2M 0.07% 258
2021
Q2
$612M Sell
14,608,900
-381,766
-3% -$14.8M 0.06% 296
2021
Q1
$505M Sell
14,990,666
-128,736
-0.9% -$4.59M 0.06% 312
2020
Q4
$528M Sell
15,119,402
-740,494
-5% -$25.6M 0.07% 263
2020
Q3
$551M Buy
15,859,896
+82,780
+0.5% +$2.76M 0.08% 241
2020
Q2
$517M Sell
15,777,116
-5,174,542
-25% -$165M 0.08% 241
2020
Q1
$631M Sell
20,951,658
-1,826,302
-8% -$54.4M 0.11% 180
2019
Q4
$659M Sell
22,777,960
-1,607,656
-7% -$44.5M 0.09% 218
2019
Q3
$630M Sell
24,385,616
-322,446
-1% -$8.15M 0.09% 216
2019
Q2
$631M Sell
24,708,062
-364,524
-1% -$9.01M 0.1% 216
2019
Q1
$656M Buy
25,072,586
+1,686,248
+7% +$41.4M 0.1% 206
2018
Q4
$539M Sell
23,386,338
-1,341,116
-5% -$29.8M 0.09% 222
2018
Q3
$583M Buy
24,727,454
+265,690
+1% +$6.48M 0.09% 232
2018
Q2
$564M Sell
24,461,764
-429,992
-2% -$10.2M 0.09% 229
2018
Q1
$613M Buy
24,891,756
+809,934
+3% +$21.3M 0.1% 199
2017
Q4
$646M Sell
24,081,822
-3,651,446
-13% -$92.9M 0.11% 206
2017
Q3
$668M Buy
27,733,268
+5,770,484
+26% +$130M 0.11% 203
2017
Q2
$471M Sell
21,962,784
-2,242,380
-9% -$45.2M 0.09% 233
2017
Q1
$415M Buy
24,205,164
+761,072
+3% +$13.3M 0.08% 249
2016
Q4
$420M Sell
23,444,092
-1,137,548
-5% -$20.6M 0.09% 237
2016
Q3
$511M Sell
24,581,640
-4,135,530
-14% -$103M 0.11% 192
2016
Q2
$772M Sell
28,717,170
-797,408
-3% -$21.9M 0.18% 134
2016
Q1
$800M Buy
29,514,578
+234,614
+0.8% +$6.29M 0.19% 124
2015
Q4
$850M Sell
29,279,964
-428,320
-1% -$11.9M 0.2% 115
2015
Q3
$806M Buy
29,708,284
+10,594,302
+55% +$300M 0.2% 121
2015
Q2
$523M Sell
19,113,982
-54,720
-0.3% -$1.54M 0.17% 133
2015
Q1
$512M Sell
19,168,702
-495,246
-3% -$11.4M 0.17% 133
2014
Q4
$416M Buy
19,663,948
+371,280
+2% +$8.29M 0.15% 149
2014
Q3
$459M Sell
19,292,668
-211,840
-1% -$4.87M 0.15% 148
2014
Q2
$450M Buy
19,504,508
+225,730
+1% +$4.98M 0.14% 149
2014
Q1
$440M Buy
19,278,778
+344,868
+2% +$7.35M 0.16% 136
2013
Q4
$350M Buy
18,933,910
+853,570
+5% +$14.9M 0.13% 183
2013
Q3
$306M Sell
18,080,340
-664,310
-4% -$11.2M 0.12% 178
2013
Q2
$290M Buy
+18,744,650
New +$312M 0.12% 165

Other funds holding NVO

Bank of America's NVO Position: Q1 2026 in Review

Bank of America reduced its Novo Nordisk (NVO) stake by 9.3% in Q1 2026, selling an estimated $52M and leaving 10,769,699 shares worth $396M. The position accounts for 0.03% of the portfolio, ranked #469.

Bank of America first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.03B in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Bank of America held 10,769,699 shares of Novo Nordisk worth $396M as of Q1 2026.
  • Bank of America sold 1,098,430 Novo Nordisk shares in Q1 2026, an estimated $52M.
  • Novo Nordisk made up 0.03% of Bank of America's portfolio in Q1 2026, its #469 holding.
  • Bank of America first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Novo Nordisk position peaked at $2.03B in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.